Comments
The World Health Organization (WHO) has lauded the emergency approvals given in India to two vaccines, from Serum Institute of India (SII) and Bharat Biotech.
“WHO welcomes the first emergency use authorisation (EUA) given to Covid-19 vaccine in the WHO South-East Asia Region. This decision taken today by India will help intensify and strengthen the fight against Covid-19 in the region,” said Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region.
“The use of vaccine in prioritised populations, along with continued implementation of other public health measures and community participation, will be important in reducing the impact of Covid-19,” she added. Serum Institute of India has a production and distribution alliance for the AstraZeneca-Oxford University vaccine in India and other low- and middle-income countries. And, envoys of more than 60 countries have visited the facilities of Bharat Biotech.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.